Dr. Steve Nissen discusses the results of three important late breaking trials looking at the impact of three drugs on cardiovascular endpoints: the CANTOS trial (Canakinumab); the REVEAL study…
Dr. Stephen Ellis discusses the results of recent trials at ACC related to Instantaneous Wave-Free Ration (iFR) and how the results impact practice in the cath lab.